ArticleBMJ open2019

Assessment of the advantage of the serum S100B protein biomonitoring in the management of paediatric mild traumatic brain injury-PROS100B: protocol of a multicentre unblinded stepped wedge cluster randomised trial.

Damien Bouvier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.